Amount of Droplet Formed During Percutaneous Dilatational Tracheostomy
Ventilatory Failure
About this trial
This is an interventional prevention trial for Ventilatory Failure focused on measuring Percutaneous Dilatational Tracheotomy, Flow controlled ventilation, droplet
Eligibility Criteria
Inclusion Criteria: percutaneous tracheostomy procedure Exclusion Criteria: whose written consent cannot be obtained who undergo surgical tracheostomy for any reason patients with active infection in the area of the procedure
Sites / Locations
- Diskapi Training and Resource HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Group 1: Tritube (FCV) used during tracheostomy
Group 2: Conventional endotracheal tube used during tracheostomy
The patient is intubated with Tritube® after the removal of the conventional endotracheal tube (ETT) and Tritube® was advanced until proximal to the carina. Before starting the PDT, measurements with ATP bioluminescence-based method (3M Clean-trace®) were made by taking sample from a sterile PVC (poly vinyl chloride) surface (10 cm2) which is held 50 cm over the operation site. After PDT with Griggs method (Portex), the measurements were repeated by taking sample from surface.
In the patient who was intubated with a conventional endotracheal tube (ETT), the tube was withdrawal to the vocal cords. Before starting the PDT, measurements with ATP bioluminescence-based method (3M Clean-trace®) were made by taking sample from a sterile PVC surface (10 cm2) which is held 50 cm over the operation site. After PDT with Griggs method (Portex), the measurements were repeated by taking sample from surface.